Effects of aerobic exercise on muscle changes in colorectal cancer survivors
Official title: Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer
Run by AdventHealth Translational Research Institute · NCT05789433 · Data updated 2026-11-12
This study tests if doing aerobic exercise can help improve muscle health in people who have survived colorectal cancer compared to those who are not exercising.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | AdventHealth Translational Research Institute Academic / other |
| Locations | 1 site (Orlando, Florida) |
| Status | Recruiting |
| Started | May 1, 2023 |
| Main results expected | March 1, 2027 |
| Study ends | March 1, 2027 |
| Registry record updated | July 3, 2025 |
| Trial ID | NCT05789433 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have completed treatment for stage I, II, or III colorectal cancer and engage in limited physical activity.
✕Probably not a fit
Patients with metastatic or recurrent colorectal cancer or those currently undergoing treatment for other cancers may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to assess how aerobic exercise training influences intermuscular adipose tissue in survivors of colorectal cancer compared to a control group receiving attention. Participants will engage in structured aerobic exercise and progressive stretching, with eligibility criteria ensuring they have completed necessary cancer treatments and are ready to exercise. The study will measure changes in muscle composition and overall health outcomes in this population.
Why it matters
Potential benefit: If successful, this study could enhance recovery and improve muscle health in colorectal cancer survivors through structured exercise.
How similar studies have gone: Other studies have shown positive outcomes with exercise interventions in cancer recovery, suggesting this approach may be beneficial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Histologically confirmed stage I, II, or III colon or rectal cancer * Completed surgical resection with curative intent * Completed other cancer-directed treatments * Engage in \<150 minutes per week of moderate- to vigorous-intensity structured endurance exercise * No planned major surgery during the study period * Readiness to exercise, as determined by a modified version of the Physical Activity Readiness Questionnaire * Ability to provide written informed consent * Provide written approval by a qualified healthcare professional * Willing to be randomized Exclusion Criteria: * Evidence of metastatic or recurrent colorectal cancer * Concurrently actively treated other (non-colorectal) cancer * Scheduled to receive other postoperative cancer-directed treatment(s) * Currently pregnant, breastfeeding, or planning to become pregnant within the next 24 weeks * Currently participating in another study with competing outcomes * Contraindications to magnetic resonance imaging * Any dietary condition or restriction that would limit tolerance of a mixed meal challenge * Any other cardiovascular, pulmonary, orthopedic, neurologic, psychiatric, or other condition that, in the investigator's opinion, would preclude participation or successful compliance with the protocol * Any other situation that, in the opinion of the investigator, would negatively impact subject safety or successful compliance with the protocol
Where it's running
-
AdventHealth
Orlando, Florida, United States Recruiting
Study contacts
- Principal investigator: Justin C. Brown, Ph.D. — AdventHealth
- Study coordinator: Justin C. Brown, Ph.D.
- Email: Justin.Brown4@AdventHealth.com
- Phone: 407-303-5600
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Platform program for evaluating treatments in metastatic HER2-positive breast cancer
This study is testing different new treatments for people with advanced HER2-positive breast cancer to see which ones work best before moving them to larger trials.
-
Characterization of the tumor microenvironment in locally advanced rectal cancer before and during neoadjuvant therapy
This observational study tests how the tumor and immune cells change in locally advanced rectal cancer from baseline to during neoadjuvant therapy using advanced genomic and immune profiling.
-
Neoadjuvant therapy for locally advanced low rectal cancer: adding fruquintinib to short-course radiotherapy with tislelizumab and CAPOX
This study tests whether adding fruquintinib to short-course radiotherapy plus tislelizumab and CAPOX before surgery helps people with locally advanced low rectal cancer achieve a better tumor response.
-
Laparoscopic vs Open Surgery for Colon Cancer in Patients with Visceral Obesity
This study tests whether laparoscopic or open surgery leads to different long-term outcomes for adults with colon cancer and visceral obesity.
-
Improving mailed FIT screening in Appalachia
This project will test whether changing the FIT kit materials and using phone versus text message navigation can help more average-risk adults in Appalachian counties complete colorectal cancer screening when they're overdue.
-
Gut and tumor bacteria patterns in metastatic versus non-metastatic colorectal cancer
This project will test whether bacteria in the gut and tumor differ between people whose colorectal cancer has spread and those whose cancer has not to see if bacterial signatures can help predict spread.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.